Home » Topics » BioWorld Science

BioWorld Science
RSS

New USP7 inhibitors identified at Shouyao Holdings

March 29, 2022

Friedrich-Alexander-University Erlangen-Nuremberg presents mu-opioid receptor agonists

March 29, 2022

Seoul National University Hospital patents triglyceride-lowering peptides

March 29, 2022

LG Chem discovers diacylglycerol O-acyltransferase 2 inhibitors

March 29, 2022

New monoglyceride lipase inhibitors identified at Roche

March 29, 2022

Missense variants in DDX39B linked to novel syndrome of global neurodevelopmental delay

March 28, 2022

Sosei Heptares' GLP-1/2 agonist HTL-0030023 shows promising results for treating NAFLD and NASH

March 28, 2022

Novartis details discovery, preclinical data of novel antimalarial compound INE-963

March 28, 2022

Novel USP30 inhibitors as potential anti-Parkinson candidates

March 28, 2022

Bayer patents P2X purinoceptor 4 antagonists

March 28, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...